Fonda Liu

644 total citations · 1 hit paper
9 papers, 457 citations indexed

About

Fonda Liu is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Fonda Liu has authored 9 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Fonda Liu's work include Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Fonda Liu is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Fonda Liu collaborates with scholars based in United States, Switzerland and Spain. Fonda Liu's co-authors include Hans‐Peter Hartung, Jerry S. Wolinsky, Catherine Lubetzki, Xavier Montalbán, David H. Miller, Dieter A. Häring, Norman Putzki, Fred Lublin, Bruce Cree and Ludwig Kappos and has published in prestigious journals such as The Lancet, Neurology and Alzheimer s & Dementia.

In The Last Decade

Fonda Liu

8 papers receiving 452 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

2016 335 citations Fred Lublin, David H. Miller et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fonda Liu United States	5	275	121	112	83	71	9	457
Nikolaos Sfikas Switzerland	10	171 0.6×	100 0.8×	76 0.7×	74 0.9×	56 0.8×	23	350
Roberta Fantozzi Italy	12	347 1.3×	155 1.3×	106 0.9×	97 1.2×	93 1.3×	26	619
G. S. M. Ramsaransing Netherlands	11	369 1.3×	91 0.8×	138 1.2×	32 0.4×	132 1.9×	13	499
Regina Berkovich United States	10	335 1.2×	30 0.2×	153 1.4×	21 0.3×	85 1.2×	33	469
Carmen Castrillo‐Viguera United States	7	83 0.3×	66 0.5×	129 1.2×	137 1.7×	26 0.4×	29	351
Cristina González‐Mingot Spain	9	84 0.3×	145 1.2×	80 0.7×	39 0.5×	19 0.3×	30	320
Sandra R. Mirandola Brazil	11	90 0.3×	230 1.9×	33 0.3×	44 0.5×	46 0.6×	11	395
Jana Švarcová Czechia	12	81 0.3×	75 0.6×	117 1.0×	124 1.5×	17 0.2×	20	385
B. A. Oostra Netherlands	7	35 0.1×	123 1.0×	179 1.6×	162 2.0×	15 0.2×	10	382
Rachel Barker United Kingdom	10	39 0.1×	142 1.2×	55 0.5×	209 2.5×	9 0.1×	18	470

Countries citing papers authored by Fonda Liu

Since Specialization

Citations

This map shows the geographic impact of Fonda Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fonda Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fonda Liu more than expected).

Fields of papers citing papers by Fonda Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fonda Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fonda Liu. The network helps show where Fonda Liu may publish in the future.

Co-authorship network of co-authors of Fonda Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fonda Liu. A scholar is included among the top collaborators of Fonda Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fonda Liu. Fonda Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Langbaum, Jessica B., Angela R. Bradbury, Brian L. Egleston, et al.. (2025). Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer’s Prevention Initiative Generation Study 1. The Lancet Healthy Longevity. 6(11). 100778–100778.

2.

Tariot, Pierre N., Marie‐Emmanuelle Riviere, Stephen Salloway, et al.. (2024). Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies. Alzheimer s & Dementia. 20(11). 7745–7761. 6 indexed citations

3.

Tariot, Pierre N., Beth Borowsky, Fonda Liu, et al.. (2020). The Generation program: Baseline characteristics of cognitively unimpaired APOE4 carriers recruited for Generation study 1 and Generation study 2. Alzheimer s & Dementia. 16(S9). 2 indexed citations

4.

Graf, Ana, Marie‐Emmanuelle Riviere, Fonda Liu, et al.. (2020). Umibecestat in the API Generation program: Worsening in RBANS and/or CDR on treatment reverses after wash‐out. Alzheimer s & Dementia. 16(S9). 6 indexed citations

5.

Rouzade‐Dominguez, Marie‐Laure, Marie‐Emmanuelle Riviere, Beth Borowsky, et al.. (2020). The API Generation program: Biomarker phenotyping of cognitively unimpaired participants screened in Generation study 1 and Generation study 2. Alzheimer s & Dementia. 16(S9). 1 indexed citations

6.

Langlois, Carolyn, Angela R. Bradbury, Elisabeth McCarty Wood, et al.. (2019). Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 705–716. 27 indexed citations

7.

Borowsky, Beth, Pierre N. Tariot, Angelika Caputo, et al.. (2019). The Alzheimer Prevention Initiative Generation Program: Evaluation of CNP520 in Preclinical Alzheimer’s Disease (P4.1-005). Neurology. 92(15_supplement). 1 indexed citations

8.

López, Cristina López, Pierre N. Tariot, Angelika Caputo, et al.. (2019). The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 216–227. 79 indexed citations

9.

Lublin, Fred, David H. Miller, Mark S. Freedman, et al.. (2016). Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. 387(10023). 1075–1084. 335 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact